Issues in the design and implementation of vaccine trials in less developed countries.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 932, doi. 10.1038/nrd2159
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2006 AND VI 5 AND IP 11
Results: 21
1
2
The obesity pipeline: current strategies in the development of anti-obesity drugs.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 919, doi. 10.1038/nrd2136
- By:
- Publication type:
- Article
3
ImClone loses Erbitux patent.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 886, doi. 10.1038/nrd2191
- By:
- Publication type:
- Article
4
Innovative lead discovery strategies for tropical diseases.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 941, doi. 10.1038/nrd2144
- By:
- Publication type:
- Article
5
Drug discovery in dementia: the role of rodent models.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 956, doi. 10.1038/nrd2075
- By:
- Publication type:
- Article
6
PI3Kγ inhibition: towards an 'aspirin of the 21st century'?
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 903, doi. 10.1038/nrd2145
- By:
- Publication type:
- Article
7
Enigmatic enzyme.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 893, doi. 10.1038/nrd2183
- By:
- Publication type:
- Article
8
Boosting genetic vaccination.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 895, doi. 10.1038/nrd2184
- By:
- Publication type:
- Article
9
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 877, doi. 10.1038/nrd2177
- Publication type:
- Article
10
Sir Alasdair Breckenridge.
- Published in:
- 2006
- By:
- Publication type:
- Interview
11
A cost-effectiveness approach to the qualification and acceptance of biomarkers.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 897, doi. 10.1038/nrd2174
- By:
- Publication type:
- Article
12
Helping hand for halting inflammation.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 896, doi. 10.1038/nrd2185
- By:
- Publication type:
- Article
13
Striking the right balance.
- Published in:
- 2006
- Publication type:
- Editorial
14
Making gains in pain.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 889, doi. 10.1038/nrd2179
- By:
- Publication type:
- Article
15
Decitabine.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 891, doi. 10.1038/nrd2180
- By:
- Publication type:
- Article
16
Downstream GPCR inhibition.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 894, doi. 10.1038/nrd2181
- By:
- Publication type:
- Article
17
Chemical genomics: Joining the small-molecule dots.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 895, doi. 10.1038/nrd2182
- By:
- Publication type:
- Article
18
Study reveals secrets to faster drug development.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 883, doi. 10.1038/nrd2189
- By:
- Publication type:
- Article
19
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 884, doi. 10.1038/nrd2190
- Publication type:
- Article
20
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 896, doi. 10.1038/nrd2186
- Publication type:
- Article
21
The trouble with making combination drugs.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 881, doi. 10.1038/nrd2188
- By:
- Publication type:
- Article